Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese.

about

Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease Lipoprotein(a): the revenant.Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables.

P2860

Q37278608-180BF1DA-EE43-451B-9139-0FC6C2E30C41 Q40280257-37CE45D0-0165-4F57-9B10-42312895C11B Q48209248-76F8E83B-E994-4466-A0E8-7523EBE22604

P2860

Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese.

Item

http://www.wikidata.org/entity/Q40899815

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese.

@en

type

Item

label

Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese.

@en

prefLabel

Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese.

@en

P1476

Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese.

@en

P2093

C-G Zhu

http://www.w3.org/2001/XMLSchema#string

C-J Cui

http://www.w3.org/2001/XMLSchema#string

J Sun

http://www.w3.org/2001/XMLSchema#string

J-J Li

http://www.w3.org/2001/XMLSchema#string

N-Q Wu

http://www.w3.org/2001/XMLSchema#string

P Qing

http://www.w3.org/2001/XMLSchema#string

Q Dong

http://www.w3.org/2001/XMLSchema#string

R-X Xu

http://www.w3.org/2001/XMLSchema#string

S Li

http://www.w3.org/2001/XMLSchema#string

S-H Yang

http://www.w3.org/2001/XMLSchema#string

P2860

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation

Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype

Lipoprotein(a) as a cardiovascular risk factor: current status

Death and dysfunction of transplanted β-cells: lessons learned from type 2 diabetes?

New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs

PCSK9: a key modulator of cardiovascular health

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor

Lipoprotein(a) and risk of type 2 diabetes

Plasma PCSK9 levels are elevated with acute myocardial infarction in two independent retrospective angiographic studies

P2888

s40618-016-0433-9

P304

875-883

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40618-016-0433-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1052469678

http://www.w3.org/2001/XMLSchema#string

P698

26894681

http://www.w3.org/2001/XMLSchema#string

P921

LPA

Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese.

about

P2860

P2860

Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921